Header Logo

Connection

RICHARD ERIC DAVIS to Mice, Transgenic

Back to Details
This is a "connection" page, showing publications RICHARD ERIC DAVIS has written about Mice, Transgenic.
RICHARD ERIC DAVIS
Connection Strength
0.019
Mice, Transgenic
  1. Antileukemia activity of the novel peptidic CXCR4 antagonist LY2510924 as monotherapy and in combination with chemotherapy. Blood. 2015 Jul 09; 126(2):222-32.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.